Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Kyana Van Acker
Profile
Projects
Publications & Research Data
Activities
Awards & Distinctions
Patents
4
Results
2025
Evaluation of a novel antisense oligonucleotide therapy targeting a 5’UTR variant in the RDH12 gene
Manon Bouckaert
Kyana Van Acker
Birthe Hilgen
Maria Georgiou
Filip Van Den Broeck
Edith De Bruycker
Alfredo Dueñas Rey
Emma Delanote
Hanne Lenaerts
Melita Kaltak
et al.
U
Conference
2025
2024
Evaluation of a novel antisense oligonucleotide therapy targeting a 5’UTR mutation in the RDH12 gene
Manon Bouckaert
Kyana Van Acker
Maria Georgiou
Filip Van Den Broeck
Margot De Moor
Edith De Bruycker
Alfredo Dueñas Rey
Emma Delanote
Hanne Lenaerts
Melita Kaltak
et al.
C3
Conference
2024
Evaluation of a novel antisense oligonucleotide therapy targeting a 5’UTR mutation in the RDH12 gene
Manon Bouckaert
Kyana Van Acker
Birthe Hilgen
Maria Georgiou
Filip Van Den Broeck
Margot De Moor
Edith De Bruycker
Alfredo Dueñas Rey
Emma Delanote
Hanne Lenaerts
et al.
C3
Conference
2024
Evaluation of a novel antisense oligonucleotide therapy targeting a 5’UTR mutation in the RDH12 gene
Manon Bouckaert
Kyana Van Acker
Maria Georgiou
Filip Van Den Broeck
Edith De Bruycker
Alfredo Dueñas Rey
Emma Delanote
Hanne Lenaerts
Melita Kaltak
Elfride De Baere
et al.
C3
Conference
2024